H.C. Wainwright analyst Amit Dayal has maintained their bullish stance on CBUS stock, giving a Buy rating on April 24.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Amit Dayal’s rating is based on several promising developments within Cibus, Inc. The company has shown potential for significant growth through its sustainable ingredients initiative, particularly in fermentation-based biofragrance products, which could alleviate some financial pressures as they continue their trait development activities. Cibus anticipates initial revenues from these products by the end of 2025, with substantial sales expected in 2026, potentially generating $20-40 million in ongoing royalty revenues.
Additionally, Cibus is advancing its agricultural trait portfolio, including weed management platforms for rice and disease resistance traits for canola and soybean. Regulatory progress in Ecuador and potential alignment with EU regulations could open new market opportunities in Latin America and Europe. These developments, along with upcoming catalysts such as new trait deliveries and potential partnerships, underpin Dayal’s optimistic outlook and Buy rating for Cibus’s stock.
According to TipRanks, Dayal is an analyst with an average return of -23.1% and a 25.00% success rate. Dayal covers the Industrials sector, focusing on stocks such as Plug Power, Joby Aviation, and Ceco Environmental.
In another report released on April 24, Canaccord Genuity also maintained a Buy rating on the stock with a $18.00 price target.

